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Abstract
Purpose—The purpose of this study is to examine the relationship between depressive symptoms 
and diabetes self-care in African American and Hispanic/Latino patients with type 2 diabetes and 
whether the association (if any) is mediated by diabetes-related self-efficacy.
Methods—The sample included self-report baseline data of African American and Hispanic/
Latino patients with type 2 diabetes aged ≥18 years enrolled in a diabetes self-management 
intervention study. Depressive symptoms were assessed with the 9-item Patient Health 
Questionnaire. The Summary of Diabetes Self-Care Activities measured engagement in healthy 
eating, physical activity, blood glucose checking, foot care, and smoking. The Diabetes 
Empowerment Scale-Short Form assessed diabetes-related psychosocial self-efficacy. Indirect 
effects were examined using the Baron and Kenny regression technique and Sobel testing.
Results—Sample characteristics (n=250) were: Mean age of 53 years; 68% female; 54% African 
American; 74% with income <$20,000. Depressive symptoms showed a significant negative 
association with self-care domains of general diet, specific diet, physical activity, and glucose 
monitoring in the African American group. In Hispanics/Latinos, depression was inversely 
associated with specific diet. Self-efficacy served a significant mediational role in the relation 
between depression and foot care among African Americans.
Conclusions—Self-efficacy mediated the relationship between depression and foot care in the 
African American group, but was not found to be a mediator of any self-care areas within the 
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Hispanic/Latino group. In clinical practice, alleviation of depressive symptoms may improve self-
care behavior adherence. Diabetes education may consider inclusion of components to build self-
efficacy related to diabetes self-care, especially among African American patients.
Keywords
diabetes self-care; depressive symptoms; self-efficacy; empowerment; type 2 diabetes; 
underserved/minority populations
Diabetes is the seventh leading cause of mortality in the US and its prevalence among 
Americans continues to grow.1 Racial/ethnic minority groups experience a greater diabetes 
burden with a documented prevalence rate two times that of their non-Hispanic white 
counterparts of similar age.1–4 These underrepresented groups also disproportionately 
experience worse glycemic control, higher rates of diabetes-related microvascular 
complications, and elevated rates of disease-related mortality.5–7 Patient engagement in self-
management behaviors recommended by the American Diabetes Association (ADA) 
remains relatively low among low socioeconomic and ethnic minority populations despite 
documented benefits of diabetes self-care for overall disease management and for 
optimization of disease-related outcomes.8–10 Symptoms of depressed and anxious mood, 
which tend to co-occur in approximately one-third of individuals with diabetes,11 is an 
evident detrimental factor negatively affecting consistent and effective engagement in self-
care practices such as physical activity and glucose monitoring.12 There is a critical need to 
identify the role of psychological factors and potential mechanistic intermediaries given low 
engagement levels across multiple diabetes self-care behaviors in low socioeconomic 
populations and ethnic/racial minorities.10
Existing literature reveals an additive detrimental effect and increased adverse health risk 
with depression and diabetes co-occurrence.13 Negative effects of comorbid depression and 
diabetes include lower medication adherence, decreased engagement in self-care and self-
management, and increased medical expenditures among others.13,14 Despite the 
documented robust inverse association, the mechanism through which depression exerts its 
influence on diabetes self-care remains uncertain. Informed by the social learning theory, it 
is hypothesized that depressive symptoms encompassing low-affect, anhedonia, and 
hopelessness unfavorably impact individual-level confidence for successful engagement in 
diabetes self-care behaviors. Deteriorated confidence, i.e., low levels of self-efficacy, would 
in turn impede completion of multiple diabetes-related self-care practices. Self-efficacy is a 
strong determinant of engagement levels across behavioral domains of diabetes self-care 
activities consequently making it a plausible mechanistic intermediary.15,16 Ample evidence 
links low levels of perceived confidence for self-care behaviors performance to low levels of 
engagement across multiple diabetes-related health domains, particularly physical activity, 
diet, and glucose monitoring.15–18 There do not appear to be any studies of the association 
between depressive symptoms and diabetes-related self-efficacy in the context of diabetes 
self-care activities, particularly in low socioeconomic populations and ethnic/racial 
minorities.
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Informed by the limited available evidence, the current study addressed the following 
research questions: (1) What is the association of depressive symptoms and diabetes self-
care behaviors in low-income African American and Hispanic/Latino patients with type 2 
diabetes?, and (2) Does diabetes-related self-efficacy mediate the relationship between 
depression and diabetes self-care in these minority patients? It is hypothesized that higher 
levels of depressive symptomatology will be associated with lower engagement levels for 
diabetes self-care behaviors, and that this association will be mediated by diabetes-related 
self-efficacy.
Materials and Methods
Study population and data source
The original data source for this study is the large randomized clinical trial (RCT) 
“Improving Diabetes Self-Management in Minorities.” Details of recruitment and the RCT 
study protocol have been published previously.19,20
Briefly, original study participants were recruited by clinic research staff across four 
federally qualified health centers (FQHCs) in underserved areas of Chicago. Inclusion 
criteria were as follows: (1) African American or Hispanic/Latino adult diagnosed with type 
2 diabetes, (2) aged 18 years or older, (3) informed and consenting adult, (4) English or 
Spanish fluency, (5) recent (within 3 months of baseline enrollment) A1C lab values greater 
than or equal to 6.5% (48 mmol/mol), (6) currently receiving hypoglycemic medication 
(insulin and/or oral agents), and (7) minimum six-month clinical diagnosis for extant 
diabetes. Race/ethnicity categorization was based on self-identification using descriptors 
similar to the US Census Bureau. Participants were excluded if they: (1) were currently 
pregnant or planning for pregnancy during the study period, (2) presented with serious 
comorbid medical (e.g., cancer) or mental health conditions, or serious complications of 
diabetes (e.g., dialysis) and (3) were unavailable via phone. Study approval was obtained 
through the Institutional Review Board (IRB) at the University of Illinois at Chicago.
Study measures
Outcome variable of self-care—Engagement in self-care behaviors was evaluated using 
the Summary of Diabetes Self-Care Activities (SDSCA) measure.21 The SDSCA is a 13-
item self-report questionnaire which inventories the relative frequency of completion of 
routine self-care tasks over the previous week. Evaluated self-care subcomponents include 
healthy eating (general [consistency in following healthful eating plan] and specific diet 
[consumption of fruits, vegetables, and high fat foods]), physical activity, blood glucose 
monitoring, foot care, medication adherence, and smoking status. Psychometric testing 
reveals suitable validity and reliability for both the English- and Spanish-language versions 
of the instrument.22 A sample item includes: “On how many of the last seven days did you 
eat five or more servings of fruits and vegetables?” With the exception of the dichotomous 
item capturing smoking status, items for each of the diabetes self-care behaviors captured 
the frequency of adherence from 0 to 7 days. Items within each self-care domain were 
averaged to calculate the mean number of days for which the self-care behaviors occurred 
(range from 0 days to 7). Self-care measures related to medication use were excluded from 
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multivariable analyses due to a ceiling effect which, consistent with other previous studies,21 
limited the utility of items estimating hypoglycemic medication use.
Depressive symptoms—The 9-item Patient Health Questionnaire (PHQ-9) is a 
psychometrically effective screening tool for depressive symptoms.23,24 The PHQ-9 uses a 
4-point Likert scale (0—Not at all to 3—Nearly every day) to probe the extent to which an 
individual has been troubled by depressive symptoms within the last two weeks; scores 
range from 0–27. For descriptive analyses, depressive symptomatology was dichotomized 
into categories of minimal (PHQ-9 <10) versus moderate to severe (PHQ-9 ≥10) using the 
clinically recommended cut-off score of 10.24
Diabetes-related self-efficacy—Psychosocial self-efficacy in the context of diabetes 
self-management was measured using the Diabetes Empowerment Scale-Short Form (DES-
SF).25 This instrument which has been validated across multiple populations in the English 
and Spanish language contains 8 items. A sample item includes, “In general, I believe that I 
am able to turn my diabetes goals into a workable plan.” Interviewees are asked to rate 
associated statements on a scale ranging from (1) strongly disagree to (5) strongly agree.
Covariates—Covariates included information on sociodemographic characteristics (age 
and income) and body mass index (BMI). BMI was calculated using self-reported measures 
of height (m2) and weight (kg).
Statistical analyses
Data analyses were conducted using statistical software (SAS 9.4; SAS, Inc, Cary, North 
Carolina). While 266 patients enrolled in the RCT, the current sample size across regression 
analyses included 250 patients with complete self-report data on the main variables of 
interest. Descriptive characteristics for the total sample are provided by depressive 
symptomatology status distinguishing those with minimal depression (PHQ-9<10) from 
those with moderate to severe depression (PHQ-9 ≥10). Group differences in participant 
characteristics across dichotomized depression categories and race/ethnicity were examined 
using F-tests and/or χ2-tests.
To test whether diabetes self-efficacy served as a mediator in the relationship between 
depression and diabetes self-care, mediational analysis was performed through use of the 
classic Baron and Kenny method.26 The predictor variable of depression was treated as a 
continuous measure and based on variable distribution, the self-care subcomponents were 
treated as count data (i.e., healthy eating, physical activity, glucose self-testing, foot care) or 
dichotomous data (i.e., smoking status). A three step modeling procedure was used as 
follows: (1) examination of the association between the dependent variable (i.e., diabetes 
self-care) and the independent variable of depressive symptomatology; (2) examination of 
the relationship between the hypothesized mediator of self-efficacy and the dependent 
variable (i.e., diabetes self-care); (3) the last step was to control for self-efficacy when 
examining the association between diabetes self-care and depressive symptoms. As a final 
step, the Sobel test27 was used to determine significant reductions in variance accounted for 
by the independent variable (i.e., depressive symptoms) after inclusion of hypothesized 
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mediator (i.e., diabetes-related psychosocial self-efficacy). Covariates in the adjusted 
regression models included age, income, and BMI.
Results
Characteristics of the study sample
Table 1 provides characteristics for the total sample along with a stratified summary by 
depression status and race/ethnicity. The sample was evenly distributed by race/ethnicity 
with 53.7% self-identifying as African American and 46.3% as Hispanic/Latino. The sample 
was primarily female (68.4%) and ranged in age from 25 to 86 years (M=53.2, SD=12.3). 
This sample was of low socioeconomic status based on education and income. Overall, 
60.0% of participants had less than a high school education and three-fourths reported an 
annual income below $20,000 (74.0%). Self-identification patterns for marital status were 
married (38.4%), never married, (24.0%), divorced (13.2%), widowed (13.2%) and 
separated (11.2%). A total of 95 (38.4%) patients reported being currently employed and 
60.3% had some type of medical care coverage. In stratified analyses, participants classified 
as having moderate to severe symptoms of depression (i.e., PHQ-9 ≥ 10) were significantly 
younger (50.3 years vs. 53.9 years), more likely to be of African American descent, reported 
lower levels of annual income, and were less likely to be married.
Descriptive information is also presented in Table 1 for profiles of body mass index and 
engagement levels across diabetes self-care activities. A mean BMI score of 33.2 (SD=7.1) 
was documented with this average value indicative of obesity using criteria from national 
guidelines.28,29 A total of 35.3% of patients self-reported use of insulin as part of their 
diabetes regimen. Over a 7-day period, self-reported diabetes self-care rates across multiple 
self-care behaviors ranged from engagement in the activity an average of 2.5 days to 6.2 
days per week. Participants reported the highest diabetes self-care scores for oral medication 
use (6.2 days/week) and lowest for physical activity (2.5 days/week). Patients presenting 
elevated symptoms of depression reported significantly lower diabetes self-care scores for 
the behaviors of general diet, specific diet, and oral medication use. Those identifying as 
current smokers were also more likely to display elevated depressive symptom profiles. Also 
see in Table 1, African Americans displayed higher BMI scores and had a greater percentage 
of members identifying as current smokers. Finally, the African American subgroup had 
higher self-care scores for blood glucose self-testing, but lower scores for the behaviors of 
specific diet and oral medication use.
Association of depressive symptoms and diabetes self-care
The first step in mediational testing is to determine whether an association exists between 
the main predictor of interest and the behavioral outcome variable(s). Table 2 presents 
stratified analysis, by race/ethnicity, on the multivariable association of depression with the 
diabetes self-care behaviors of diet, physical activity, glucose self-testing, foot care, and 
smoking. In the African-American subgroup, depressive symptoms were found to be 
significantly associated with the self-care domains of general (β = −0.032; P = 0.01) and 
specific diet (β = −0.020; P = 0.02), physical activity (β = −0.046; P < 0.01), and glucose 
monitoring (β = −0.020; P = 0.01); a trend toward significance was evident for the self-care 
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domain of foot care (β = −0.013; P = 0.09). Negative parameter estimates reveal an inverse 
relationship between depressive symptomatology and the above-mentioned self-care 
behaviors suggesting that higher depressive symptoms scores are associated with lower self-
care performance levels. Only specific diet was significantly associated with depressive 
symptoms in the Hispanic/Latino subgroup with a negative beta suggesting an inverse 
relationship (see Table 2); trends toward significance were observed for the self-care 
behaviors of general diet and foot care.
Mediational testing procedures and role of self-efficacy
As illustrated in Figure 1, Step 2 of the mediational analysis (path a) requires examination of 
the direct effect of depressive symptoms on self-efficacy. For the African American 
subgroup (see Table 3), depressive symptomatology was significantly associated with self-
efficacy in the unadjusted model (β = −0.024; P = 0.01), while displaying a trend toward 
significance after addition of relevant covariates (β = −0.019; P = 0.06). No such association 
was evident in the Hispanic/Latino patient subgroup. In lieu of results for initial mediational 
testing, i.e., paths a and c depicted in Figure 1, final analytic regression steps were 
conducted only for the African American subgroup for the self-care behaviors of diet, 
physical activity, glucose self-testing, and foot care.
Table 4 presents the results for the final step of the mediational analysis for the African 
American subsample. Across self-care behaviors of general diet (β = −0.029; P < 0.01), 
specific diet (β = −0.019; P = 0.04), and glucose self-testing (β = −0.020; P = 0.02), 
consistency and robustness of statistical significance for depression was evident even after 
inclusion of the hypothesized mediator of self-efficacy. This suggests that complete and 
partial mediation via self-efficacy was not achieved. Self-efficacy was found to be 
significantly associated with physical activity (P=0.02) and foot care (P=0.02), with larger 
self-efficacy scores associated with higher self-care performance levels. In the mediational 
model, diabetes-specific self-efficacy was significantly associated with physical activity with 
an observed decrease in magnitude for the P-value corresponding to depressive 
symptomatology. Nonetheless, the Sobel test confirmed that partial mediation was not 
achieved for the outcome measure of physical activity given the minor change in magnitude 
in the P-value for the construct of depression; not depicted in the tables, the Sobel test 
resulted in an associated P-value of 0.12. For the outcome measure of foot care, depressive 
symptomatology was no longer significant after the inclusion of diabetes-related self-
efficacy, suggesting a significant mediational role via the construct of self-efficacy; note, a 
significant bivariate association was evident in unadjusted models displaying a correlational 
P-value of 0.03 for depressive symptoms and foot care in the African American cohort.
Discussion
In the context of the current state of knowledge, what follows is a discussion of the 
association between depressive symptoms and diabetes self-care behaviors in low-income 
African American and Hispanic/Latino patients, with consideration of whether self-efficacy 
plays a mediational role. Recruited from federally qualified health centers in Chicago, the 
current study included a clinical sample of adult, low income, African American and 
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Hispanic/Latino patients with type 2 diabetes. Exceeding rates expected for the general US 
population, 24.8% of the current cohort was considered to have moderate to severe 
symptoms of depression based on the PHQ-9. Engagement in diabetes self-care behaviors 
displayed a considerable range from 2.5 days/week for physical activity to 6.2 days/week for 
oral medication adherence. This is consistent with prior work suggesting low self-care 
adherence levels in minority populations, particularly in the complex areas of exercise and 
home glucose monitoring.10 In the African American subgroup, self-efficacy was shown to 
mediate the relationship between depressive symptoms and foot care.
The first stage of mediational testing revealed that higher depressive symptomatology scores 
were associated with lower engagement levels across self-care activities of diet, physical 
activity, glucose monitoring, and an evident trend toward significance for the domain of foot 
care. The current cross-sectional findings are consistent with prior research.13,14 Multiple 
studies with and without inclusion of racial/ethnic minority subsamples with type 1 and 2 
diabetes produce robust evidence documenting an inverse relationship between depressive 
symptomatology and performance of self-care activities, with higher depression scores 
associated with lower levels of self-care activities. Research also indicates that the 
magnitude of depressive symptoms experienced, i.e., minor versus major depression, seems 
of less import as even subthreshold levels can reduce engagement in positive health 
behaviors.30 Although there are multiple hypotheses, the mechanistic pathway through 
which depression impacts engagement in self-care activities remains relatively obscure.
The current study documents differential effects by race/ethnicity, whereby the negative link 
between depressive symptoms and self-care was more robust for the African American 
subgroup. Differential experience of and disease-specific manifestation across ethnic/racial 
groups has been suggested in prior literature.31,32 Methodological limitations, i.e., sample 
size and low variance in depression scores, could explain less robust associations of 
depression and self-care in the Hispanic/Latino subsample. The sample size of 112 could 
have limited the power to detect clinically meaningful associations, with relatively fewer 
Hispanic/Latino adults reporting elevated depressive symptom thresholds, i.e., 17.2% (H/L) 
vs. 31.3% (AA). The larger number of Hispanics/Latinos with favorable psychological well-
being and limited variance in depression scores could have impacted findings.
The current study appears to be the first to explore the role of self-efficacy in the relationship 
between depressive symptoms and self-care in a low-income cohort of ethnic/racial minority 
patients with diabetes. Self-efficacy was an important construct in the relational pathway 
between depressive symptoms in only one self-care area, foot care, and only for the African 
American cohort. Foot care results for the African American subgroup are consistent with 
prior research. Among African Americans with a chronic condition (e.g., hypertension), 
greater self-efficacy scores have been linked with more favorable health behavior profiles 
such as augmented participation in physical activity, medication adherence, and healthful 
dietary intake. Schoenthaler et al.33 found self-efficacy to mediate the relationship between 
depressive symptoms and medication adherence in African American adults with 
hypertension. Similar results are evident in the context of type 2 diabetes.34 It is 
hypothesized that negative cognitive appraisals resulting from depression diminish personal 
confidence and subsequent engagement in self-care activities.33 Replication studies using 
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large epidemiologic cohorts are needed to confirm the mechanistic role of self-efficacy in the 
relationship between depressive symptoms and foot care to refute possibility of a false 
positive relationship. Nuanced investigations should additionally test why and to what extent 
self-efficacy is of import for foot care but not other self-care areas and only in one racial/
ethnic subgroup.
Emphasizing the importance of not treating minority groups in aggregate, divergent 
functioning of self-efficacy was evident by race/ethnicity when examining the link between 
depressive symptoms and foot care. It is possible that ethnic or cultural factors lead to 
differential manifestations of depression31,32 and to divergent effects on feelings of 
confidence and mastery. Multiple studies document the concept of fatalismo in the Hispanic/
Latino community in the context of chronic illness management;35 fatalismo is defined as, 
“a doctrine that events are fixed in advance so that human beings are powerless to change 
them.”36,37 Intrinsic belief that illness management is outside of the individual locus of 
control may serve to attenuate the negative effects triggered by symptoms of depression. In 
effect, it is possible that fatalistic beliefs that diabetes and its complications are inevitable 
may result in an overall reduction in confidence in the performance of diabetes self-
management behaviors over and above that produced by depression and its associated 
symptoms. This hypothesis is supported by findings linking higher scores of diabetes-related 
fatalism with lower engagement levels across diabetes self-care activities.35 A second 
hypothesis posits that depression may be more intricately tied to self-efficacy in the African 
American subgroup (for foot care and when compared to Hispanics/Latinos), if Hispanics/
Latinos with literacy and language barriers already experience deteriorations in self-
confidence beyond the additive effect brought about by symptoms of depression. Challenges 
associated with limited English proficiency include reduced effectiveness in the use of health 
information, multiple barriers when attempting to navigate the health service system, and the 
mandatory need for interpretation services when attempting to communicate with non-
Spanish speaking health providers.
The present study has multiple strengths. This is the first study to examine the mediational 
role of self-efficacy in the relationship between depressive symptoms and diabetes self-care 
in a population composed of underserved U.S. Hispanic/Latino and African American 
patients with diabetes. Well-validated instruments were used to assess symptoms of 
depression, diabetes-related self-efficacy, and self-care behaviors across multiple domains. 
Social desirability bias was possibly reduced as assessments were completed on a 
computerized tablet. However, study limitations should be considered when interpreting 
findings. As self-report instruments were employed, measurement error and 
misclassification bias are plausible across psychosocial constructs and behavioral 
engagement levels. Determination of depression status was based solely on a self-report 
measure (i.e., PHQ-9) and not a clinical diagnosis made by a mental health provider. As with 
all cross-sectional studies, the design does not permit for assumptions of inferences about 
causality. Specifically, it is possible that individuals display lower levels of depressive 
symptomatology as a consequence of elevated feelings of positive affect related to favorable 
profiles of diabetes self-care activities.38 Longitudinal studies are needed to adequately 
address uncertainties regarding temporality of the association. Finally, although the majority 
of enrolled Latino participants were of Mexican background, this study was limited in 
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characterizing the heterogeneity across the Hispanic/Latino subgroup (e.g., excluding 
information such as cultural assimilation).
Implications and Recommendations
The findings for the current study offer multiple implications for healthcare practitioners 
seeking to optimize diabetes management in minority populations. Findings confirm low 
levels of self-care in African American and Hispanic/Latino adult with type 2 diabetes, 
particularly for complex behavior such as physical activity and glucose self-monitoring. 
Innovative, accessible, and cost-effective behavioral and educational interventions are 
needed to augment and support engagement in diabetes self-management behaviors in these 
underserved groups.
Second, heightened co-occurrence of depressive symptoms in patients with diabetes 
suggests the need to bolster screening efforts to detect psychological challenges with 
implementation of interventions as needed (e.g., cognitive behavioral therapy). Proper 
treatment, pharmacological and/or psychotherapeutic, should be implemented to improve 
psychological functioning given its impact of self-care adherence. Finally, given the 
mediational role of diabetes-related self-efficacy, it may be beneficial to measure this 
construct across patient populations with an action plan to provide support as necessary. 
Previous studies have made similar clinical practice recommendations regarding the need to 
augment diabetes-related self-efficacy, with interventions developed to empower patients to 
take charge of their physical and emotional well-being.39 In clinical practice, diabetes 
education may consider inclusion of components to build self-efficacy related to diabetes 
self-care, especially among African American patients.
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Figure 1. 
Baron and Kenny Mediational Model Test
Hernandez et al. Page 12
Diabetes Educ. Author manuscript; available in PMC 2017 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Hernandez et al. Page 13
Ta
bl
e 
1
Ch
ar
ac
te
ris
tic
s o
f t
he
 S
tu
dy
 S
am
pl
e 
by
 D
ep
re
ss
io
n 
St
at
us
 a
nd
 R
ac
e/
Et
hn
ic
ity
 (N
 =2
50
)
Va
ri
ab
le
To
ta
l
M
od
er
at
e 
to
Se
v
er
e
D
ep
re
ss
iv
e
Sy
m
pt
om
s
(P
HQ
-9≥
10
)
M
in
im
al
D
ep
re
ss
iv
e
Sy
m
pt
om
s
(P
HQ
-9<
10
)
P-
v
a
lu
e
A
fr
ic
an
 A
m
er
ic
an
La
tin
o
P-
v
a
lu
e
So
ci
od
em
og
ra
ph
ic
 C
ha
ra
ct
er
ist
ic
s
N
 =
 2
50
A
ge
, M
 
(S
D)
53
.2
 ±
 1
2.
3
50
.3
 ±
 1
2.
1
53
.8
 ±
 1
2.
1
0.
04
51
.8
 ±
 1
3.
0
54
.7
 ±
 1
1.
5
0.
06
Fe
m
al
e,
 %
68
.4
70
.5
67
.6
0.
63
65
.8
71
.4
0.
32
R
ac
e/
Et
hn
ic
ity
,
 
%
 
 
A
fri
ca
n 
A
m
er
ic
an
53
.7
67
.2
48
.4
0.
01
-
-
-
-
-
-
 
 
H
isp
an
ic
/L
at
in
o
46
.3
32
.8
51
.6
-
-
-
-
-
-
Ed
uc
at
io
n,
 %
 
 
<
 H
ig
h 
Sc
ho
ol
60
.0
58
.0
61
.1
0.
64
37
.9
85
.2
<
0.
00
1
 
 
H
ig
h 
Sc
ho
ol
 G
ra
du
at
e
18
.8
22
.6
17
.3
29
.5
7.
0
 
 
>
 H
ig
h 
Sc
ho
ol
21
.2
19
.4
21
.6
32
.6
7.
8
A
nn
ua
l h
ou
se
ho
ld
 in
co
m
e,
 %
 
 
Le
ss
 th
an
 $2
0,0
00
74
.0
85
.4
70
.7
0.
04
70
.9
78
.9
0.
21
 
 
M
or
e 
th
an
 $2
0,0
00
26
.0
14
.6
29
.3
29
.1
21
.1
Em
pl
oy
m
en
t S
ta
tu
s, 
%
 
 
Cu
rre
nt
ly
 E
m
pl
oy
ed
38
.4
38
.7
38
.4
0.
98
31
.8
t4
6.
1
0.
06
 
 
U
ne
m
pl
oy
ed
21
.6
21
.0
22
.2
22
.7
20
.9
 
 
O
th
er
40
.0
40
.3
39
.4
45
.5
33
.1
H
ea
lth
 In
su
ra
nc
e,
 %
 
 
Ye
s
60
.3
69
.0
57
.1
0.
11
66
.4
53
.5
0.
04
 
 
N
o
39
.7
31
.0
42
.9
33
.6
46
.5
M
ar
ita
l S
ta
tu
s, 
%
 
 
M
ar
rie
d
38
.4
27
.4
42
.2
0.
01
22
.7
56
.5
<
0.
00
1
 
 
N
ev
er
 M
ar
rie
d
24
.0
37
.1
19
.5
38
.6
7.
0
 
 
O
th
er
37
.6
35
.5
38
.4
38
.6
36
.5
Diabetes Educ. Author manuscript; available in PMC 2017 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Hernandez et al. Page 14
Va
ri
ab
le
To
ta
l
M
od
er
at
e 
to
Se
v
er
e
D
ep
re
ss
iv
e
Sy
m
pt
om
s
(P
HQ
-9≥
10
)
M
in
im
al
D
ep
re
ss
iv
e
Sy
m
pt
om
s
(P
HQ
-9<
10
)
P-
v
a
lu
e
A
fr
ic
an
 A
m
er
ic
an
La
tin
o
P-
v
a
lu
e
B
io
be
ha
v
io
ra
l F
ac
to
rs
B
M
I, 
M
 
(S
D)
33
.1
 ±
 7
.1
34
.4
 ±
 9
.2
32
.8
 ±
 6
.2
0.
21
34
.6
 ±
 7
.7
31
.6
 ±
 5
.9
0.
00
1
G
en
er
al
 D
ie
t, 
M
 
(S
D)
3.
7 
± 
2.
3
3.
1 
± 
2.
2
3.
8 
±2
.3
0.
03
3.
6 
± 
2.
2
3.
7 
±2
.4
0.
89
Sp
ec
ifi
c 
D
ie
t, 
M
 
(S
D)
4.
0 
± 
1.
6
3.
1 
± 
1.
3
4.
2 
±1
.7
<
 0
.0
01
3.
7 
± 
1.
4
4.
3 
± 
1.
8
0.
00
8
Ph
ys
ic
al
 A
ct
iv
ity
,
 
M
 
(S
D)
2.
5 
± 
2.
1
2.
3 
± 
1.
9
2.
6 
±2
.2
0.
41
2.
7 
± 
1.
9
2.
3 
± 
2.
3
0.
20
B
lo
od
 G
lu
co
se
 C
he
ck
in
g,
 M
 
(S
D)
3.
6 
± 
2.
7
3.
7 
± 
2.
4
3.
6 
±2
.8
0.
77
4.
1 
± 
2.
5
3.
0 
± 
2.
8
0.
00
1
M
ed
ic
at
io
n,
 M
 
(S
D)
 
 
In
su
lin
4.
9 
± 
0.
7
4.
2 
± 
3.
1
5.
2 
±2
.8
0.
07
5.
2 
±2
.7
4.
3 
± 
3.
2
0.
12
 
 
O
ra
l M
ed
ic
at
io
n/
Pi
lls
6.
2 
± 
2.
0
5.
5 
± 
2.
6
6.
5 
±1
.6
0.
01
5.
7 
±2
.4
6.
8 
± 
1.
1
<
0.
00
1
Fo
o
t C
ar
e,
 M
 
(S
D)
4.
5 
± 
2.
5
4.
3 
± 
2.
5
4.
6 
±2
.4
0.
39
4.
6 
± 
2.
4
4.
5 
± 
2.
5
0.
84
Sm
ok
in
g,
 %
 
 
Ye
s
21
.3
32
.3
18
.1
0.
02
27
.6
14
.7
0.
01
3
 
 
N
o
78
.7
67
.7
81
.9
72
.4
85
.3
Diabetes Educ. Author manuscript; available in PMC 2017 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Hernandez et al. Page 15
Ta
bl
e 
2
St
an
da
rd
iz
ed
 re
gr
es
sio
n 
w
ei
gh
ts 
(P
 
v
al
ue
s) 
for
 di
ab
ete
s s
elf
-ca
re 
me
asu
res
 re
gr
es
se
d 
on
 c
ov
ar
ia
te
s a
nd
 d
ep
re
ss
iv
e 
sy
m
pt
om
s (
PH
Q-
9)a
,
 
by
 ra
ce
/e
th
ni
ci
ty
G
en
er
al
 D
ie
t
Sp
ec
ifi
c 
D
ie
t
Ph
ys
ic
al
 A
ct
iv
ity
G
lu
co
se
 M
on
ito
ri
ng
Fo
o
t C
ar
e
Sm
ok
in
g 
St
at
us
R
ac
e/
Et
hn
ic
Su
bg
ro
u
p
C
oe
ffi
ci
en
t
Es
t. 
(β)
, S
E
P-
v
a
lu
e
C
oe
ffi
ci
en
t
Es
t. 
(β)
, S
E
P-
v
a
lu
e
C
oe
ffi
ci
en
t
Es
t. 
(β)
, S
E
P-
v
a
lu
e
C
oe
ffi
ci
en
t
Es
t. 
(β)
, S
E
P-
v
a
lu
e
C
oe
ffi
ci
en
t E
st
.
(β)
, S
E
P-
v
a
lu
e
C
oe
ffi
ci
en
t
Es
t. 
(β)
, S
E
P-
v
a
lu
e
A
fri
ca
n 
A
m
er
ic
an
−
0.
03
2 
(0.
01
)
<
0.
01
−
0.
02
0 
(0.
00
9)
0.
02
−
0.
04
6 
(0.
01
)
<
0.
01
−
0.
02
0 
(0.
00
8)
0.
01
−
0.
01
3 
(0.
00
8)
0.
09
−
0.
05
3 
(0.
04
)
0.
13
H
isp
an
ic
/L
at
in
o
−
0.
02
1 
(0.
01
)
0.
06
−
0.
03
0 
(0.
01
)
<
0.
01
−
0.
00
1 
(0.
01
)
0.
92
0.
01
3 
(0.
01
)
0.
25
−
0.
01
9 
(0.
01
)
0.
06
−
0.
07
6 
(0.
05
)
0.
15
a A
dju
ste
d f
or 
ag
e, 
inc
om
e, 
an
d b
od
y m
ass
 in
de
x
.
Diabetes Educ. Author manuscript; available in PMC 2017 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Hernandez et al. Page 16
Table 3
Standardized regression weights (P value) for diabetes self-efficacy regressed on covariates and depressive 
symptoms (PHQ-9) a, by race ethnicity
Hispanic/Latino Subgroup African American Subgroup
Depressive Symptoms Coefficient Est.
(β), SE
P-value Coefficient Est.
(β), SE
P-value
M1: Unadjusted 0.004 (0.012) 0.73 −0.024 (0.010) 0.01
M2: Multivariable Adjusteda 0.004 (0.012) 0.75 −0.019 (0.010) 0.06
aAdjusted for age, income, and body mass index.
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